8-K: Acadia Healthcare Forecasts Lower 2026 Capex, Bed Growth

Acadia Healthcare Company, Inc. announced preliminary 2026 guidance including a significant reduction in capital expenditures and planned bed additions, alongside interim third-quarter 2025 patient day growth.

Summary

• Preliminary 2026 guidance includes expected total capital expenditures to decline by at least $300 million relative to the 2025 guidance of $600 million to $650 million.
• The company expects to add 500 to 700 beds in 2026, inclusive of beds currently under construction in 2025.
• Same facility patient days growth to date for the third quarter of 2025 is approximately 1.3%.

Sentiment

Score: 7

Explanation: The company provided positive preliminary guidance for 2026 with a substantial reduction in capital expenditures and continued bed growth, alongside modest same-facility patient day growth. However, significant regulatory risks, particularly from the newly enacted OBBBA affecting Medicaid, introduce uncertainty.

Positives

• Expected decline in capital expenditures by at least $300 million in 2026, suggesting improved capital efficiency or completion of major projects.
• Planned addition of 500 to 700 beds in 2026 indicates continued expansion of capacity.
• Same facility patient days growth of approximately 1.3% for Q3 2025 to date suggests ongoing demand for services.

Risks

• Potential difficulties in successfully integrating the operations of acquired facilities or realizing the expected benefits and synergies of facility expansions, acquisitions, joint ventures, and de novo transactions.
• Ability to add beds, expand services, enhance marketing programs, and improve efficiencies at facilities.
• Potential reductions in payments received from government and commercial payors, including significant changes to Medicaid financing mechanisms introduced by the One Big Beautiful Bill Act (OBBBA) enacted on July 4, 2025.
• Occurrence of patient incidents, governmental investigations, litigation, and adverse regulatory actions, which could affect common stock price and result in substantial payments and incremental regulatory burdens.
• Risk of not generating sufficient cash from operations to service debt and meet working capital and capital expenditure requirements.
• Potential disruptions to information technology systems or a cybersecurity incident.
• Potential operating difficulties, including disruption to the U.S. economy and financial markets; reduced admissions and patient volumes (partially due to OBBBA's introduction of work or community engagement requirements in the Medicaid expansion population); increased costs relating to labor, supply chain, and other expenditures; changes in competition and client preferences; and general economic or industry conditions.

Future Outlook

Acadia Healthcare provided preliminary 2026 guidance, projecting a reduction in capital expenditures by at least $300 million from 2025 levels and an addition of 500 to 700 beds. The company also reported approximately 1.3% same facility patient days growth for the third quarter of 2025 to date.

Management Comments

• Senior management is scheduled to participate in a fireside chat at the Jefferies 2025 Healthcare Services Conference.
• The company is providing preliminary guidance for 2026 with respect to expected total capital expenditures and bed growth.
• The company is also providing a select interim operating result for the third quarter of 2025.

Industry Context

The healthcare services industry, particularly behavioral health, is subject to regulatory changes and reimbursement pressures, as highlighted by the newly enacted One Big Beautiful Bill Act (OBBBA) impacting Medicaid financing and patient volumes. Acadia Healthcare's planned bed growth indicates continued expansion in a sector with ongoing demand, while the reduction in capital expenditures may reflect a focus on capital efficiency amidst evolving industry dynamics.

Stakeholder Impact

• Shareholders: Potential for improved capital efficiency and continued growth, but also exposure to regulatory risks (OBBBA) and general economic conditions.
• Patients: Expected addition of 500 to 700 beds suggests increased access to healthcare services.
• Employees: Continued expansion and operations imply stable to growing employment opportunities.
• Government/Commercial Payors: Impacted by potential reductions in payments and changes to Medicaid financing mechanisms due to OBBBA.

Next Steps

• Senior management team to participate in a fireside chat at the Jefferies 2025 Healthcare Services Conference on September 29, 2025.
• Further details on how same facility results are calculated and the company's rationale for presenting them can be found in the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.

Key Dates

Recommendation

While the preliminary 2026 guidance indicates positive trends in capital efficiency with a significant reduction in projected capital expenditures and continued bed growth, and interim Q3 2025 patient days show modest growth, the newly enacted One Big Beautiful Bill Act (OBBBA) introduces substantial regulatory and reimbursement uncertainty, particularly concerning Medicaid. This creates a balanced outlook where positive operational indicators are tempered by significant legislative risks, warranting a 'hold' position until the full impact of OBBBA can be better assessed.

Keywords

Acadia Healthcare, ACHC, Healthcare Services, Capital Expenditures, Bed Growth, Patient Days, SEC Filing, 8-K, Medicaid, OBBBA